“Existing technologies will not deliver the breakthrough performance required to realize the full potential of the DNA economy … something different, and truly innovative is required.”

— Paul Mola, CEO and Founder

Our Goal: Precision Medicine

Current prevention and treatment of disease is not precisely tailored to each individual's unique variability in genes, environment and lifestyle. Precision medicine should begin with complete knowledge of the individual's genome, however, current whole-genome DNA sequencing technology is still too costly, too complex and low accuracy to use in precision medicine at the population scale. Roswell's sequencing technology was specifically designed to disrupt the current technologies and deliver an "endgame" sequencing platform, ideal for the future of global precision medicine.

Our Team

The Roswell founders and leadership team have uniquely broad and deep experience in genomics, from fundamental technology development, to global commercialization, to population-scale applications. We are comprised of seasoned business leaders and experienced scientists, engineers and technologists, on a mission to revolutionize precision medicine.
Learn More

In The News

OMICS, May/June 2018

"Roswell is taking a bold step to develop a transformative technology platform based on Molecular Electronics"

Read More

GenomeWeb, 10. January 2018

"Roswell Biotechnologies Harnesses Molecular Electronics for Chip-Based DNA Sequencing"

Read More

Leadership Team

Paul Mola

President, CEO & Founder, Director

Paul Mola is the Chief Executive Officer and President of Roswell Biotechnologies, Inc., and a member of the company's board of directors. He founded Roswell in 2014, bringing more than 20 years of Life Science industry leadership and executive experience to the company. Paul manages corporate direction and strategy combining science and business knowledge to build highly talented and effective teams across corporate, business and technical functions. Previously, Paul was Head of Global Solutions at Human Longevity, Inc., working with genome sequencing pioneer Craig Venter to establish international precision medicine partnerships.
Barry M

Barry Merriman, Ph.D.

CSO & Co-Founder, Director

Dr. Merriman is the co-Founder and Chief Science Officer of Roswell Biotechnologies, and a member of the company's board of directors. Dr. Merriman brings to the company over 30 years of broad experience in scientific research and technology development, with deep expertise in DNA sequencing technology and associated applications. Dr. Merriman is the architect of the Roswell technology roadmap, oversees the company's research and development, leads the creation of its intellectual property, and builds strategic relationships with science and technology partners. Dr. Merriman has published extensively in the scientific literature and is a highly regarded international lecturer in these fields.

Tim Geiser, Ph.D.

Head of Intellectual Property and Licensing

Dr. Geiser is the Vice President of Intellectual Property and Licensing at Roswell Biotechnologies. Dr. Geiser has over 40 years of experience in life sciences technology and business development. His achievements include pioneering the development of the first instruments for DNA synthesis and peptide synthesis, two cornerstones of modern biotechnology. Dr. Geiser manages Roswell's IP portfolio, leads licensing efforts, and plays a key role in developing the company's IP strategy and strategic partnerships.

Gina Costa, Ph.D.

Head of Systems Integration

Dr. Costa is the VP of Research and Development at Roswell Biotechnologies. Dr. Costa has over 20 years of experience in the genomics industry, including key roles in the creation and commercialization of four independent DNA sequencing platforms. Dr. Costa directs all R&D operations, leads project management, and drives the day-to-day R&D efforts. Dr. Costa is a proven leader and technology innovator who has successfully built and led multi-disciplinary R&D teams from small biotech entities to large corporate and globally directed organizations. As a recognized expert in genomics Dr. Costa's affiliations include the American Association of Immunologists (AAI), the International Review Committee (IRC) for the Canadian government on its national R&D funding strategy for genomic technology, and has over 50 peer-review publications in molecular biology, immunology and genomics.

Sungho Jin, Ph.D.

Head of Nanofabrication

Dr. Jin is the Chief Architect for Nanofabrication at Roswell. He brings to the company over 40 years of experience as a leading authority in materials science and nanofabrication. Dr. Jin is a Professor Emeritus at the University of California, San Diego, where he was a Distinguished Professor of Materials Science and held the Sony Endowed Chair in Engineering. Prior to that, Dr. Jin was one of the elite group of Technical Directors at Bell Labs, overseeing the area of Applied Materials. Dr. Jin is internationally recognized as one of the leading experts in nanotechnology and has won numerous national honors.

Drew Hall, Ph.D.

Head of Chip Design

Dr. Hall is the Chief Architect for Chip Design at Roswell Biotechnologies. He brings to the company cutting-edge industry experience in designing CMOS chips for high-performance biosensors. Dr. Hall is the architect of the Roswell chip technology roadmap, leads the company's chip design program, and manages the chip design and electrical engineering teams. In addition to his work at Roswell, Dr. Hall holds a position as Assistant Professor in Electrical Engineering at University of California, San Diego, where he leads the Biosensor Research Program. Dr. Hall has an extensive background in designing CMOS integrated circuits for bioelectronics, biosensors, lab-on-chip devices, and other biomedical devices and systems.
Austin Tomanney

Austin Tomaney

Head of Software Algorithm

Dr. Tomaney is a Principal Engineer at Roswell Biotechnologies. He has 20 years of experience in technology development in life sciences specializing in image and signal processing. Most recently he has brought this experience to the design and optimization of early breadboard to commercial release single molecule sequencing systems at Pacific Biosciences.

Eskild Hansen

Chief Design Officer

Eskild Hansen is the founder of Eskild Hansen Design Studios and Chief Design Officer of international companies that have focus on taking design to the next level Before this he was the Global Director of Design at Coloplast, responsible for the global design strategy, the multi-disciplinary design team, projects and for external partners. The vision was to use design to create the most innovative medical device company in the world Before this, Eskild was the Head of the Cisco European Design Center. Over the six years in this leadership role, he managed the multi-disciplinary European design team and formulated the vision and strategies for the implementation and execution of large global Cisco Consumer projects.
Michael Geremia

Michael Geremia

Head of Finance

Scientific Advisory Board

Professor James Tour

Rice University Departments of Chemistry, Computer Science, Materials Science, and NanoEngineering, member of AAAS and NAI.
Professor Tour is regarded as one of the fathers of Molecular Electronics having lead the effort to make the first molecular circuit, which was heralded by the Journal Science as a Breakthrough of the Year in 2000. Professor Tour advises Roswell on all areas regarding Molecular Electronics including molecular conductors, molecular circuits, and synthetic chemistry for nanotechnology. Professor Tour is an expert in synthetic organic chemistry for diverse applications in nanotechnology and nanoelectronics, and is Director of the Center for Carbon Nanotechnology at Rice University. He has received numerous honors for his pioneering work in molecular electronics and nanotechnology.

Professor Eli Yablonovitch

UC Berkeley Department of Electrical Engineering and Computer Science
Professor Yablonovitch is a world leading expert in quantum electronics, quantum photonics, and nano-scale engineering. Professor Yablonovitch advices Roswell in the fiels of nanotechnology including nano-Electronics, nano-Fabrication, and semiconductors. He has received numerous awards for his fundamental contributions in physics and engineering, including the Isaac Newton Medal and the Edison Medal, two of the highest honors in these fields. He is recognized as one of the fathers of modern photonics and the Inventor of the Photonics Crystal, a foundational technology for semiconductors in communication.

Professor Stanley Osher

UCLA Departments of Mathematics and Computer Science
Professor Osher is a world-leading expert in Data Sciences and the development of algorithms for computer simulation and data analysis. He advises Roswell in the area of Informatics, including signal processing, data analysis, algorithms, and data science. He has received many awards for his fundamental contributions to the fields of applied math, computational math, and computer science. Professor Osher is the Director of Special Projects at IPAM, a US National Research Center for Pure and Applied Mathematics. Professor Osher is one of the most widely cited computer scientists in history and is widely recognized as the father of modern signal processing methods.

Professor George Church

Harvard University Department of Genetics
Professor Church is a world leading expert in the technologies used to study and manipulate the genome, and a pioneer in DNA sequencing technology, genome editing technology, and synthetic biology. He advises Roswell in the area of Genomics, including protein engineering, synthetic biology and genomic technology. He has won numerous awards for his fundamental contributions to genomics, including the Bower Award for Achievement in Science, and the American Society for Microbiology Biotechnology Research Award. Professor Church introduced many of the techniques fundamental to current genome sequencing technology, has cofounded numerous companies in the areas of genomics and genetics, and was one of the originators of the Human Genome Project.

Professor Sandy Schmid

UT Southwestern Department of Cellular and Molecular Biology
Professor Schmid is an expert in fundamental processes of cellular biology. She advises Roswell in the area of Molecular Biology, including protein engineering, biochemistry, and molecular conjugation. She is a Distinguished Chair in Cellular and Molecular Biology and Chairman of the Department of Cell Biology at UT Southwestern Medical Center. She was previously Chairman of the Department of Cellular and Molecular Biology at Scripps Research Institute in San Diego. She is a member of the American Academy of Arts and Sciences and President of the American Society for Cell Biology.

Professor Stanley F. Nelson, MD

UCLA Departments of Human Genetics, Pediatrics, and Psychiatry
Professor Nelson is a leading expert in the development and application of genomic technologies for use in medicine and medical research. He advises Roswell in the area of Medical Applications of Genomics, including genetic disease, clinical sequencing, biomarkers, and drug discovery. Dr. Nelson is credited with inventing the original DNA microarray technology and its applications to genomics at the Brown Lab in Stanford in 1990. This technology provided the foundation for much of modern genomics research, as well as the later development of Next Generation Sequencing technology. Dr. Nelson has done extensive work finding the genes responsible for human inherited disease and cancer, as well as developing genomics-based therapies for genetic disease.

Board of Directors

John Kip Miller

Mr. Miller is an accomplished executive and entrepreneur with a proven track record of developing and growing global life science businesses, most notably at Life Technologies (now ThermoFisher Scientific) and BD Biosciences. Mr. Miller has built a strong background in executive leadership, M&A, and commercial operations and has developed extensive experience in the segments of cellular analysis, genomics and diagnostics.

Until 2011, he served as SVP and President of the Genetic Systems at Life Technologies, an approximately $1B division of a market-leading provider of DNA sequencing systems developed for academic research, applied market segments for human identification, and clinical diagnostics.

Prior to the formation of Life Technologies, Kip served as Senior Vice President of Invitrogen (2005-2008) where he led the ~$650M Biodiscovery division. During his tenure the company became the market-leading developer and provider of tools and enabling technologies for biomedical research involved in molecular biology, proteomics and cellular analysis.

Before joining Invitrogen Corporation, Mr. Miller served as Vice President and General Manager at BD Biosciences from November 1992 to November 2005. During this period, Mr. Miller owned responsibility for the development of BD Biosciences research flow cytometry instrumentation, research immunology reagents and for the company’s Commercial Operations across the Americas.

Currently Mr. Miller is actively involved as an independent board member at Celsee, Biological Dynamics and Tonbo Biosciences.

Susan Smalley, Ph.D.

Susan Smalley is a behavioural geneticist, writer and activist. The co-author of Fully Present: The Science, Art, and Practice of Mindfulness, she is the founder of the UCLA Mindful Awareness Research Center at the Jane and Terry Semel Institute of Neuroscience and Human Behavior (MARC), and professor emerita in the department of psychiatry and biobehavioral sciences at UCLA. Her research centered on the genetic basis of childhood-onset disorders such as autism and attention deficit hyperactivity disorder (ADHD) and her lab conducted the first genome-wide scan of ADHD. She has published more than 100 peer-reviewed papers, has lectured globally on the genetics of human behavior and the science of mindfulness and is a contributor to online Psychology Today and Huffingtonpost.

Smalley is a co-founder of PTK Capital, a family investment fund focused on investing in companies that can significantly benefit the world while assuring economic growth. PTK invests in life science technologies, health and wellness, and new media while attending to ideal business practices including promoting gender equality. Dr. Smalley sits on the board of directors for Equality Now, an international human rights organization focused on women and girls; previously served on Gordon and Sarah Brown's High Level Panel for the Global Campaign for Education; and Roswell Biotechnologies,. She also serves on the scientific advisory board of Stop Breathe and Think, a meditation app that delivers tools for emotional wellbeing including mindfulness and meditation, and co-founded Cell-Ed, a platform to bring basic literacy to adults in underserved populations using mobile phones.

Arthur Bilger

Art Bilger is Founder and CEO of WorkingNation, a national not-for-profit campaign to educate the American public about the looming unemployment crisis in this country and to start a widespread movement to meet and overcome this unprecedented challenge.

Art continues to be an active investor in early stage private companies engaged in new technologies, with particular focus on healthcare, online education, digital media, and data analytics. Art’s activities in this area began as an investor in and Vice Chairman of Akamai Technologies Inc., a provider of global, high-performance services for the delivery of internet content, streaming media and applications. Prior to this, Art was involved in the formation of New World Communications, which became the largest Fox Broadcasting affiliate group where he also became President, Chief Operating Officer and a Director. Prior career involvements included a founding partner of Apollo Advisors, LP, one of today’s largest private equity firms and EVP and Co-Head of Corporate Finance of Drexel Burnham Lambert.

Art serves as a member of the University of Pennsylvania's Wharton School Board of Overseers and sits on its Executive Committee. Also at Wharton, Art sits on the Board and is the Founding Funder of the Wharton Customer Analytics Initiative, an entity focused on the evolution of data analytics in the corporate world. Other non-profit affiliations include Vice Chairman of the Skirball Cultural Center, a board member of Bet Tzedek, a legal services organization, the Advisory Board for the Milken Institute Center for the Future of Aging, a member of Los Angeles County Economic Development Corporation (LAEDC), a member of the Los Angeles Coalition for the Economy and Jobs and a member of the UCLA Health System Board.

Art Bilger's successful career began with the completion of his B.S. in Economics from the University of Pennsylvania and subsequent MBA from The University of Chicago.

Paul Mola

Paul Mola

Paul Mola is the Chief Executive Officer and President of Roswell Biotechnologies, Inc., and a member of the company's board of directors. He founded Roswell in 2014, bringing more than 20 years of Life Science industry leadership and executive experience to the company. Paul manages corporate direction and strategy combining science and business knowledge to build highly talented and effective teams across corporate, business and technical functions. Previously, Paul was Head of Global Solutions at Human Longevity, Inc., working with genome sequencing pioneer Craig Venter to establish international precision medicine partnerships.
Barry Merriman

Barry Merriman, Ph.D.

Dr. Merriman is the co-Founder and Chief Science Officer of Roswell Biotechnologies, and a member of the company's board of directors. Dr. Merriman brings to the company over 30 years of broad experience in scientific research and technology development, with deep expertise in DNA sequencing technology and associated applications. Dr. Merriman is the architect of the Roswell technology roadmap, oversees the company's research and development, leads the creation of its intellectual property, and builds strategic relationships with science and technology partners. Dr. Merriman has published extensively in the scientific literature and is a highly regarded international lecturer in these fields.